Abstract
The outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) has caused approximately 64,000 cases of Corona Virus Disease (COVID-19) in China so far, with that number continuing to grow. To control the spread of the disease, screening large numbers of suspected cases for appropriate quarantine and treatment measures is a priority. Viral nucleic acid testing based on specimens from the lower respiratory tract is the diagnostic gold standard. However, the availability and quality of laboratory testing in the infected region presents a challenge,so alternative diagnostic methods are urgently needed to combat the disease. Based on COVID-19 radiographical changes in CT images, we hypothesized that Artificial Intelligence’s deep learning methods might be able to extract COVID-19’s specific graphical features and provide a clinical diagnosis ahead of the pathogenic test, thus saving critical time for disease control. To test this possibility, we collected 453 CT images of pathogen-confirmed COVID-19 cases along with previously diagnosed with typical viral pneumonia. 217 images were used as the training set and the inception migration-learning model was used to establish the algorithm. The internal validation achieved a total accuracy of 82.9% with specificity of 80.5% and sensitivity of 84%. The external testing dataset showed a total accuracy of 73.1% with specificity of 67% and sensitivity of 74%. These results indicate the great value of using the deep learning method to extract radiological graphical features for COVID-19 diagnosis.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* Equal contribution
Competing Interest Statement: The authors have declared no competing interest.
Funding Statement: None
Data Availability
All data referred to in the manuscript is available.